PROMIS CAT forms demonstrate responsiveness in patients following reverse shoulder arthroplasty across numerous health domains: Responsiveness of PROMIS after RSA
Recommended Citation
Franovic S, Taylor K, Kuhlmann N, Aboona F, Schlosser C, and Muh SJ. PROMIS CAT forms demonstrate responsiveness in patients following reverse shoulder arthroplasty across numerous health domains: Responsiveness of PROMIS after RSA. Seminars in Arthroplasty 2020; 30(1):28-34.
Document Type
Article
Publication Date
5-1-2020
Publication Title
Seminars in arthroplasty
Abstract
Background: To better optimize the administration and postoperative tracking of patients using PROM, the Patient-Reported Outcomes Measurement Information System (PROMIS) was established by the National Institutes of Health. PROMIS CAT domains have been since validated in multiple orthopedic interventions of the shoulder. However, no one to date has studied the responsiveness of PROMIS CAT domains in a cohort of patients undergoing reverse shoulder arthroplasty. The purpose of this study was to investigate the responsiveness of three PROMIS CAT domains in patients undergoing reverse shoulder arthroplasty.
Methods: Patients undergoing reverse shoulder arthroplasty by a board-certified shoulder and elbow surgeon were included in this study. PROMIS CAT Upper Extremity Physical Function (“PROMIS-UE”), Pain Interference (“PROMIS-PI”), and Depression (“PROMIS-D”) scores were collected preoperatively and at five postoperative timepoints. Patient-centric demographic factors, range of motion, and clinical characteristics were also reviewed and analyzed for association with PROMIS scores.
Results: 104 patients undergoing primary reverse shoulder arthroplasty were included in this study. The patient cohort consisted of 52 males (50%), with an average age of 70.3 years (standard deviation, 11.2), and a BMI of 30.2 (standard deviation, 6.1). All three PROMIS domains showed significant improvement as early as 6 weeks after surgery, with values of 32.4 ± 6.6, 56.2 ± 7.5, and 44.6 ± 8.6, for PROMIS-UE, PROMIS-PI, and PROMIS-D, respectively. Significant improvements were noted for each postoperative timepoint thereafter, with 1-year follow-up values as follows: 42.1 ± 8.7, 52.5 ± 8.6, and 43.6 ± 9.5 for PROMIS-UE, PROMIS-PI, and PROMIS-D, respectively. Moderate correlations were identified with postoperative PROMIS-UE and abduction (r = 0.439, p < 0.01), as well as postoperative PROMIS-PI and PROMIS-D (r = 0.502, p < 0.01).
Conclusions: PROMIS CAT forms demonstrate responsiveness in patients undergoing reverse shoulder arthroplasty.
Level of Evidence: Level II; Retrospective Study.
PubMed ID
Not assigned.
Volume
30
Issue
1
First Page
28
Last Page
34